Senti Biosciences (SNTI) Stock: Why It Surged Over 20% Today

By Amit Chowdhry ● Sep 29, 2022
  • The stock price of Senti Biosciences (SNTI) surged by over 20% pre-market today. This is why.

The stock price of Senti Biosciences (SNTI) surged by over 20% pre-market today. 

Why: Bullish research report

Price target: $7

Rating: Buy

Analyst: BofA Securities analyst Greg Harrison

Harrison adjusted the rating while noting that Senti’s gene circuit platform is differentiated and offers the potential to attack new cancer targets with fewer on-target off-tumor effects compared to current approaches. And Harrison sees a significant unmet need in the initially targeted indications of acute myeloid leukemia and hepatocellular carcinoma and thinks peak unadjusted revenues greater than $1 billion in 2031.